• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Non-HDL cholesterol and apoB in dyslipidaemia.

作者信息

Sniderman Allan D, Hogue Jean-Charles, Bergeron Jean, Gagné Claude, Couture Patrick

机构信息

The Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Royal Victoria Hospital, Montreal, QC, Canada.

出版信息

Clin Sci (Lond). 2008 Jan;114(2):149-55. doi: 10.1042/CS20070265.

DOI:10.1042/CS20070265
PMID:17868037
Abstract

On the basis of a high correlation, non-HDL-C (non-high-density lipoprotein cholesterol) and apoB (apolipoprotein B) have been suggested to be of equivalent value for clinical practice; however, the strength of this relationship has not been examined in detail in patients with dyslipidaemia. The present study examines the variance of non-HDL-C compared with apoB in 1771 consecutive patients evaluated in a lipid clinic. These patients were divided into normolipidaemic subjects (n=407), type I hyperlipoproteinaemia (n=16), type IIa (n=736) and IIb (n=231) hyperlipoproteinaemia, type III hyperlipoproteinaemia (n=38), type IV hyperlipoproteinaemia (n=509) and type V hyperlipoproteinaemia (n=101). The relationship between non-HDL-C and apoB was examined both in terms of correlation and concordance. Correlation was high, but concordance was only moderate in the normolipidaemic subjects and in those with type IIa and type IIb hyperlipoproteinaemia. Correlation and concordance were both low in the subgroups with type III and type V hyperlipoproteinaemia. In those with type IV hyperlipoproteinaemia, correlation was moderately high (r=0.74), but concordance was only fair. In conclusion, our results indicate that there is substantial variance of apoB for given values of non-HDL-C in many dyslipidaemic subjects. It follows that correlation is not adequate as a sole judge of equivalence of laboratory parameters.

摘要

相似文献

1
Non-HDL cholesterol and apoB in dyslipidaemia.
Clin Sci (Lond). 2008 Jan;114(2):149-55. doi: 10.1042/CS20070265.
2
Lipoprotein fractions in idiopathic hyperlipoproteinaemia.特发性高脂蛋白血症中的脂蛋白组分
Acta Physiol Pol. 1982 Jan-Apr;33(1-2):47-56.
3
Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.肾移植术后患者的脂质、脂蛋白及富含甘油三酯的脂蛋白紊乱,以及空腹和非空腹非高密度脂蛋白胆固醇情况。
Ren Fail. 2007;29(6):705-12. doi: 10.1080/08860220701460111.
4
[Biochemical diagnosis of hereditary hyperlipoproteinemias].[遗传性高脂蛋白血症的生化诊断]
Ter Arkh. 1998;70(4):9-15.
5
Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).辛伐他汀联合非诺贝特治疗混合性高脂血症患者期间非高密度脂蛋白胆固醇及低密度脂蛋白胆固醇与载脂蛋白B的相关性(SAFARI试验的亚分析)
Am J Cardiol. 2009 Aug 15;104(4):548-53. doi: 10.1016/j.amjcard.2009.04.018.
6
[Fatty acid composition of phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. I. Relation to HDL lipoprotein].[高脂蛋白血症中磷脂酰胆碱的脂肪酸组成及脂质和脂蛋白水平。I. 与高密度脂蛋白的关系]
Cas Lek Cesk. 1998 Jun 15;137(12):368-71.
7
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.阿托伐他汀对2型糖尿病患者低密度脂蛋白及非高密度脂蛋白胆固醇与载脂蛋白B关系的影响:甘油三酯和胆固醇酯转运蛋白的修饰作用
Expert Opin Ther Targets. 2009 Jul;13(7):743-51. doi: 10.1517/14728220903023866.
8
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.载脂蛋白B与载脂蛋白A-I比值、总胆固醇与高密度脂蛋白比值、非高密度脂蛋白胆固醇或高敏C反应蛋白作为急性冠脉综合征后接受他汀治疗患者临床风险预测指标的预后价值:来自PROVE IT-TIMI 22研究的结果
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):424-30. doi: 10.1161/ATVBAHA.108.181735. Epub 2009 Jan 2.
9
Blood plasma apolipoproteins A-I and B in different types of hyperlipoproteinaemia: comparative analysis of population groups in Moscow and Prague.不同类型高脂蛋白血症患者血浆载脂蛋白A-I和B:莫斯科与布拉格人群组的比较分析
Cor Vasa. 1988;30(3):168-76.
10
The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment.载脂蛋白B和载脂蛋白A1检测对心血管风险评估的贡献。
Diabetes Obes Metab. 2008 Apr;10(4):271-8. doi: 10.1111/j.1463-1326.2007.00714.x.

引用本文的文献

1
Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study.17年随访后动脉僵硬度的脂蛋白颗粒预测指标:马尔默饮食与癌症研究
Int J Vasc Med. 2020 Apr 28;2020:4219180. doi: 10.1155/2020/4219180. eCollection 2020.
2
Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.非高密度脂蛋白胆固醇与 LDL 颗粒测量值之间的差异:来自动脉粥样硬化多民族研究的结果。
Atherosclerosis. 2013 Aug;229(2):517-23. doi: 10.1016/j.atherosclerosis.2013.03.012. Epub 2013 Mar 26.
3
ApoB versus non-HDL-C: what to do when they disagree.
载脂蛋白B与非高密度脂蛋白胆固醇:意见不一致时该怎么办。
Curr Atheroscler Rep. 2009 Sep;11(5):358-63. doi: 10.1007/s11883-009-0054-2.